Portage Biotech resumes patient enrollment for PORT-6 trial, aiming to evaluate therapeutic potential alongside PORT-7 in cancer treatment. Portage Biotech Inc. has announced the resumption of ...
A split-second decision while driving past a skin cancer clinic may have saved Tony Stoll's life. The Port Lincoln man swung ... He said he had not lost a single patient. "It's probably the ...
West Coast General Hospital (WCGH) Foundation has helped the hospital purchase a new Mammotome for the operating room with a ...
Wednesday announced the resumption of patient enrollment in the fourth and final cohort of the dose escalation stage for PORT-6, a highly selective A2A antagonist, within its ADPORT-601 Phase 1b ...